Aerobic Glycolysis: a Novel Target in Kidney Cancer

Overview

Journal Expert Rev Anticancer Ther

Specialties Oncology
Pharmacology

Date 2013 Jun 19

PMID 23773105

Citations 47

Authors

Brian Shuch

W Marston Linehan

Ramaprasad Srinivasan

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma (RCC) is a heterogenous group of cancers that arise from the nephron. While there are distinct histologic subtypes associated with common genetic alterations, most forms of RCC are linked by a common pathway of dysregulated metabolism. Reliance on aerobic glycolysis, a feature of cancer first hypothesized by Warburg, is a common feature in sporadic and hereditary forms of kidney cancer. Two hereditary forms of RCC, succinate dehydrogenase (SDH) and hereditary leiomyomatosis and RCC (HLRCC), are characterized by mutations in Krebs cycle enzymes, rendering them dependent on glycolysis for energy requirements. The reliance on these pathways may make them vulnerable to novel metabolic strategies, including inhibition of glycolysis, glucose uptake and macromolecule biosynthesis.

Citing Articles

S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression.

Deng M, Liao S, Deng J, Li C, Liu L, Han Q Cell Death Dis. 2025; 16(1):135.

PMID: 40011447 PMC: 11865524. DOI: 10.1038/s41419-025-07418-1.

Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis.

Xu Y, Yu C, Zhang H, Wang T, Liu Y, Wu L J Cancer. 2024; 15(17):5577-5593.

PMID: 39308682 PMC: 11414613. DOI: 10.7150/jca.97277.

TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma.

Li J, Huang K, McBride F, Sadagopan A, Gallant D, Thakur M bioRxiv. 2024; .

PMID: 39149323 PMC: 11326252. DOI: 10.1101/2024.08.09.607311.

MetalinksDB: a flexible and contextualizable resource of metabolite-protein interactions.

Farr E, Dimitrov D, Schmidt C, Turei D, Lobentanzer S, Dugourd A Brief Bioinform. 2024; 25(4).

PMID: 39038934 PMC: 11262834. DOI: 10.1093/bib/bbae347.

Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.

Koltai T, Fliegel L Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931411 PMC: 11206832. DOI: 10.3390/ph17060744.

References

Mazurek S . Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2010; 43(7):969-80. DOI: 10.1016/j.biocel.2010.02.005. View

Herman J, Latif F, Weng Y, Lerman M, Zbar B, Liu S . Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994; 91(21):9700-4. PMC: 44884. DOI: 10.1073/pnas.91.21.9700. View

Hara S, Oya M, Mizuno R, Horiguchi A, Marumo K, Murai M . Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor. Ann Oncol. 2005; 16(6):928-33. DOI: 10.1093/annonc/mdi182. View

Adam J, Hatipoglu E, OFlaherty L, Ternette N, Sahgal N, Lockstone H . Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell. 2011; 20(4):524-37. PMC: 3202623. DOI: 10.1016/j.ccr.2011.09.006. View

Wise D, DeBerardinis R, Mancuso A, Sayed N, Zhang X, Pfeiffer H . Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008; 105(48):18782-7. PMC: 2596212. DOI: 10.1073/pnas.0810199105. View

Astuti D, Latif F, Dallol A, Dahia P, Douglas F, George E . Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001; 69(1):49-54. PMC: 1226047. DOI: 10.1086/321282. View

Gill A, Pachter N, Chou A, Young B, Clarkson A, Tucker K . Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol. 2011; 35(10):1578-85. DOI: 10.1097/PAS.0b013e318227e7f4. View

REED W, Walker R, Horowitz R . Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol. 1973; 53(5):409-16. DOI: 102340/0001555553409416. View

Vander Heiden M, Christofk H, Schuman E, Subtelny A, Sharfi H, Harlow E . Identification of small molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol. 2009; 79(8):1118-24. PMC: 2823991. DOI: 10.1016/j.bcp.2009.12.003. View

10.

Dang C, Le A, Gao P . MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009; 15(21):6479-83. PMC: 2783410. DOI: 10.1158/1078-0432.CCR-09-0889. View

11.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

12.

Garber K . Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst. 2004; 96(24):1805-6. DOI: 10.1093/jnci/96.24.1805. View

13.

Grubb 3rd R, Franks M, Toro J, Middelton L, Choyke L, Fowler S . Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007; 177(6):2074-9. DOI: 10.1016/j.juro.2007.01.155. View

14.

Baba M, Hong S, Sharma N, Warren M, Nickerson M, Iwamatsu A . Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A. 2006; 103(42):15552-7. PMC: 1592464. DOI: 10.1073/pnas.0603781103. View

15.

Lehtonen H, Kiuru M, Ylisaukko-Oja S, Salovaara R, Herva R, Koivisto P . Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet. 2005; 43(6):523-6. PMC: 2564537. DOI: 10.1136/jmg.2005.036400. View

16.

Baysal B, Ferrell R, Willett-Brozick J, Lawrence E, Myssiorek D, Bosch A . Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000; 287(5454):848-51. DOI: 10.1126/science.287.5454.848. View

17.

Chan D, Sutphin P, Nguyen P, Turcotte S, Lai E, Banh A . Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011; 3(94):94ra70. PMC: 3683134. DOI: 10.1126/scitranslmed.3002394. View

18.

Wang J, Erickson J, Fuji R, Ramachandran S, Gao P, Dinavahi R . Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010; 18(3):207-19. PMC: 3078749. DOI: 10.1016/j.ccr.2010.08.009. View

19.

Shi D, Xie F, Zhai C, Stern J, Liu Y, Liu S . The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer. 2009; 8:32. PMC: 2702299. DOI: 10.1186/1476-4598-8-32. View

20.

Selak M, Armour S, MacKenzie E, Boulahbel H, Watson D, Mansfield K . Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005; 7(1):77-85. DOI: 10.1016/j.ccr.2004.11.022. View